Corcept Therapeutics INC (CORT) — 8-K Filings

8-K Filings (14)

• CORCEPT THERAPEUTICS Files 8-K for 'Other Events' on March 25, 2026 — Mar 25, 2026
  CORCEPT THERAPEUTICS INC filed an 8-K on March 25, 2026, under Item 8.01, indicating 'Other Events.' While the filing itself doesn't detail the specific event,
• 8-K Filing — Dec 31, 2025
• Corcept Therapeutics Terminates Material Agreement — Oct 14, 2025 Risk: medium
  Corcept Therapeutics Inc. filed an 8-K on October 14, 2025, reporting the termination of a material definitive agreement. The filing does not provide specific d
• Corcept Therapeutics Files 8-K on Officer/Director Changes — Oct 6, 2025 Risk: medium
  On October 6, 2025, Corcept Therapeutics Incorporated filed an 8-K report. The filing indicates changes related to the departure of directors or certain officer
• Corcept Therapeutics Files 8-K — Sep 10, 2025 Risk: low
  On September 10, 2025, Corcept Therapeutics Incorporated filed an 8-K report. The filing primarily concerns "Other Events" and "Financial Statements and Exhibit
• Corcept Therapeutics Files 8-K — Jul 14, 2025 Risk: low
  Corcept Therapeutics Inc. filed an 8-K on July 14, 2025, reporting on other events and financial statements/exhibits. The filing does not contain specific finan
• Corcept Therapeutics Files 8-K on Shareholder Votes & Financials — Jun 16, 2025 Risk: low
  Corcept Therapeutics Incorporated filed an 8-K on June 16, 2025, reporting on matters submitted to a vote of security holders and financial statements as of Jun
• Corcept Therapeutics Files 8-K — Mar 31, 2025 Risk: low
  Corcept Therapeutics Inc. filed an 8-K on March 31, 2025, reporting other events and financial statements. The filing does not contain specific details on new e
• Corcept Therapeutics Files 8-K — Mar 3, 2025 Risk: low
  Corcept Therapeutics Inc. filed an 8-K on March 3, 2025, reporting other events and financial statements/exhibits. The filing does not contain specific details
• Corcept Therapeutics Files 8-K — Dec 30, 2024 Risk: low
  Corcept Therapeutics Inc. filed an 8-K on December 30, 2024, reporting on other events and financial statements. The filing does not contain specific financial
• Corcept Therapeutics Announces New CMO Employment Agreement — May 23, 2024 Risk: low
  Corcept Therapeutics Incorporated announced on May 17, 2024, that it has entered into a new employment agreement with its Chief Medical Officer, Dr. Vera. The a
• Corcept Therapeutics Enters Material Definitive Agreement — Apr 17, 2024 Risk: medium
  Corcept Therapeutics Inc. entered into a material definitive agreement on April 12, 2024. This agreement involves a direct financial obligation or an obligation
• Corcept Therapeutics Files 8-K on Operations & Financial Condition — Jan 8, 2024
  Corcept Therapeutics Incorporated filed an 8-K on January 8, 2024, to report on its results of operations and financial condition, as well as other events. This
• Corcept Therapeutics Files Routine 8-K on Jan 2, 2024 — Jan 2, 2024
  Corcept Therapeutics Incorporated filed an 8-K on January 2, 2024, to report an 'Other Event' and 'Financial Statements and Exhibits'. This filing is a routine

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX